Towa Pharmaceutical Co., Ltd. (TYO:4553)
Japan · Delayed Price · Currency is JPY 3,345.00
-35.00 (-1.04%)
Nov 13, 2026, 3:30 PM JST
Towa Pharmaceutical Stock Forecast
Stock Price Forecast
According to 6 analysts polled by S&P Global, Towa Pharmaceutical stock has a consensus rating of "Buy" and an average price target of ¥5,267. The average 1-year stock price forecast is 57.45% higher than the current stock price, while the lowest is ¥4,200 (+25.56%) and the highest is ¥6,300 (+88.34%).
Price Target: ¥5,267 (+57.45%)
Analyst Consensus: Buy
Price Target
Chart* Price targets were last updated on Jun 12, 2026.
Analyst Ratings
The average analyst rating for Towa Pharmaceutical stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Oct '26 | Nov '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Buy | 0 | 1 | 1 | 1 | 1 | 1 |
| Hold | 2 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Buy Upgrades ¥4,500 → ¥5,600 | Buy | Upgrades | ¥4,500 → ¥5,600 | +67.41% | Jun 12, 2026 |
Financial Forecast
Revenue This Year
305.43B
from 273.71B
Increased by 11.59%
Revenue Next Year
330.85B
from 305.43B
Increased by 8.32%
EPS This Year
457.24
from 106.65
Increased by 328.74%
EPS Next Year
463.76
from 457.24
Increased by 1.43%
Financial currency is JPY.